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Introduction
With advancing age, there is an increased risk of multimorbidity [1] , which results in multiple drugs being prescribed [2] [3] [4] [5] [6] . This polypharmacy has been identified as the main determinant of potentially inappropriate drug prescribing (PIDP) [7] [8] [9] , highly prevalent in nursing home (NH) residents [10] [11] [12] [13] ranging from 11.5% to 62.5% [14, 15] , and may contribute to adverse outcomes [8, [16] [17] [18] [19] [20] [21] [22] [23] . PIDP is associated with greater use to health care systems [24, 25] and to poor quality of life.
Various interventions to reduce potentially inappropriate prescribing have been investigated. These interventions include educational approaches, pharmacists' medication reviews, or the use of computerized decision support systems (CDSS) [26] [27] [28] [29] [30] [31] . However, there is still a low level of evidence that these interventions reduce medication-related problems and improve medication appropriateness [30] . There is a need to identify effective interventions to optimize drug prescribing and resident outcomes.
The IQUARE (Impact d'une demarche QUAlité sur l'évolution des pratiques et le déclin fonctionnel des Résidents en EHPAD) study aimed to improve NH quality indicators by promoting closer relationships between NH medical staff and geriatricians [6] . The intervention implemented was a general intervention not directly focused on drug prescribing.
Because the high rate of PIDP observed at baseline [9, [32] [33] [34] [35] , our aim was to investigate whether this general intervention achieved success in reducing PIDP at 18-month follow-up.
Methods
IQUARE was a multicentric controlled trial performed in NHs from South-Western France (trial registration number: NCT01703689). IQUARE's protocol was fully described elsewhere [6] ; it will be briefly reported herein. This was a 6-month intervention, with an 18-month follow-up. The intervention tested in the IQUARE study took place in three phases: a first phase of diagnosis, a second phase of support and finally a third phase of assessment. It was not specifically focused on drug prescribing. The intervention was based on the realization of a shared self-assessment of the quality of the medical care of the residents (i.e. audit), accompanied by a critical restitution (i.e. feedback) to the NH, of an individualized support of each NH by a hospital geriatrician of the closest hospital (20 hospital geriatricians in total), and of an inter-NH collective support by sub-regions of health [i.e. concentric areas determined by the regional health authorities to organize care networks (usually around medium-sized or large towns)] led by the departmental delegations. The project involved in its approach NHs, hospital geriatricians, and all stakeholders and health professionals in the sub-region of health including general practitioners. Part of prescribers, the coordinating physician, the director of the NH and coordinating nurses attended the education. This intervention was participatory, formative and sustained. The feedback was carried out in a standardized way, but the intervention could be personalized at each NH and according to the expectations and possibilities of each other. There was not an interrater comparison of how the education intervention was delivered. NHs were allocated to: (i) audit and feedback intervention on quality indicators associated to cooperative work meetings between hospital geriatricians and NH staff (intervention group); or (ii) audit and feedback only (control group). All NH received descriptive statistics on their own structure, residents' health status and indicators of quality presented as prevalence and compared to the mean value observed in NHs in the same area [for example prevalence of cognitive assessment performed in residents reported as dement; prevalence of residents evaluated for pain; prevalence of residents with more than two psychotropic drugs, with long halflife benzodiazepines (BZD)]. In NH receiving intervention, these statistics were critically discussed during two half-day meetings by a working group including the NH staff and a geriatrician. According to the specific weaknesses and strengths identified in the NH, strategies to improve quality indicators were decided on an individual case basis. IQUARE followed the principles of the Declaration of Helsinki and complied with ethical standards in France; study protocol was approved by the ethic committee of the Toulouse University Hospital and the Consultative Committee for Treatment of Research information on Health (CNIL: 07-438).
Participants
For this study investigating the effectiveness of the intervention on PIDP, we used data of residents present at the follow-up time-point among the 974 residents initially analysed [9] . Residents receiving end of life care were excluded because of the specific objectives of their drug therapy. The selection process is described in Figure 1 .
Procedures
Data were collected at baseline (May-July 2011) and 18 months later (November 2012-March 2013). The administrative staff (coordinating physician or administrator)
Figure 1
Flowchart of nursing homes and study subjects completed the questionnaire about NH structure and organization, and the medical staff (coordinating physician or referent nurse) completed the resident-related questionnaire after collecting information on residents' health status.
For each participant, all drugs prescribed in the week of data collection were collected, and coded according to the Anatomical Therapeutic Chemical (ATC) classification [36] .
PIDP at 18 months was assessed as previously reported at baseline [9] . The comprehensive drug utilization review (DUR) of drug prescriptions used all available clinical data: age, sex, weight, stature, creatinine clearance and patient's comorbidities. The DUR was conducted by nine experienced pharmacists [a coordinating pharmacist (C.C.) and 8 other pharmacists]. All potential drug-related problems were identified and classified for each resident ( Table 4 ). The DUR was performed by two reviewers (eight pairs of reviewers including the coordinating pharmacist and one of the eight other pharmacists).
Outcome measure
The primary outcome PIDP was assessed by using different sources: contraindications and drug-drug interactions reported in the Summary of Product Characteristics [37, 38] ; the Laroche list [39] including drugs with an unfavourable benefit-to-risk ratio and/or with questionable efficacy; the recommendations of good clinical practice by the French High Authority of Health (HAS) [40] ; and residents' clinical data.
PIDP was dichotomously coded (resident had or did not have PIDP) and was defined as the presence of at least one of the following criteria: (i) drug with an unfavourable benefit-to-risk ratio; (ii) drug with questionable efficacy; (iii) absolute contraindication; (iv) significant drug-drug interaction.
The secondary outcomes were defined by each component of the primary outcome.
Resident characteristics
We considered the following variables available at the follow-up time-point: demographic characteristics (age, sex); prescribed drugs; and medical characteristics [dementia, depression, epilepsy, psychiatric diseases (excluding depression), physical aggressive behaviour, re-evaluation of drug prescriptions since the admission into the NH, activity of daily living dependencies (0-2, 2.5-4, 4.5-6; a total score of 6 indicates full function and 0 indicates severe disability), the Charlson Comorbidity Index (CCI; 0, 1, ≥ 2 comorbidities), fall in the last 12 months and number of hospitalizations in the last 12 months (0, 1, ≥ 2)].
Nursing home characteristics
Because the intervention was done at the NH level, NH characteristics were considered as covariates. Structural variables were: ownership status (public, private: nonprofit and for profit), presence of a Special Care Unit (for patients with dementia), presence of a comprehensive geriatric care network (NH located in a geographic area with the following facilities: a day hospital, an hospital acute geriatric care unit, a geriatric outreach team and a memory clinic), number of general practitioners per 100 beds, geriatric academic training of coordinating physician (high-level: postgraduate diploma in geriatrics, intermediate-level: other training on geriatrics or specific training of coordinating physician, low-level: none of the specified before). Organizational variables were: presence of a pharmacy for internal usage (e.g, a pharmacy and a pharmacist inside the NH), presence of computerized medical charts, access to geriatric advice and/or to hospitalization in a geriatric unit (very easy or easy vs. none or difficult), access to psychiatric advice and/or to hospitalization in a psychiatric unit (very easy or easy vs. none or difficult), presence of a drug formulary used by general practitioners prescribing in the NH.
Statistical analysis
Characteristics of residents were compared according to their group (intervention or control). Comparisons between categorical variables were performed using chi-square or Fisher's exact tests (for expected values <5). Student t tests were used for continuous variables.
Analysis of the effect of the intervention on PIDP was based on multilevel regression model to account for the hierarchical structure of the data (residents -level 1 -grouped by NHs -level 2) and the possibility that they could be correlated. This approach allowed testing the association between PIDP and the resident characteristics and, independently, the intervention and the NH characteristics. If there was a significant variability between NHs on the outcome [41] , a multilevel model was applied; otherwise, a fixed effects logistic regression was used. To test variability between NHs on the outcome, we computed a first model, called the null model (Model 1), including only random level-2 variable identifying each NH. Individual characteristics with a P value < 0.25 in the bivariate analysis were then simultaneously introduced in the model (Model 2). From this Model 2, NH characteristics were introduced one by one using a manual forward stepwise regression procedure. Finally, a manual backward stepwise regression procedure excluded variables with a significance level of 0.05. Multicollinearity was checked by using the variance inflation factor. All variables were included after testing the interactions between covariates (with a significance level 0.05) [42] . Models were performed for the primary outcome (PIDP) and for each component of the primary outcome separately. All models were adjusted for age, sex and CCI to control for potential confounding effects. Goodness-of-fit for the logistic regression models was considered acceptable if Hosmer-Lemeshow test had a P value > 0.05 [43] . All analyses were conducted using SAS 9.3 ™ software (SAS Institute Inc., NC, USA), with exception of multilevel analyses, for which Stata 11 software (Stata Corp., College Station, TX, USA) was used.
Results

Characteristics of the study population (residents) and nursing homes
Among the 974 residents at baseline, 645 were still present at follow-up but 16 were excluded because of end of life (Figure 1 ). Fifty-five residents were lost to follow-up [corresponding to the 12 NHs not participating in the follow-up time-point, due to administrative issues (change of coordinating physician)], and 274 dropped out (243 died, 17 changed of institution, eight returned home, five were transferred to at long-term care unit and one had unavailable data). The rate of dropouts was similar in in the intervention and the control groups [n = 130 (28.3%) vs. n = 144 (28.0%)]. PIDP was investigated among a total of 629 residents: 290 (76 NHs) in the intervention group and 339 (83 NHs) in the control group. Patients' characteristics (Table 1) were similar whatever the group, except that patients in the intervention group were older and more frequently hospitalized. Table S1 presents characteristics of residents according to the presence or not of PIDP. NH characteristics (aggregated at the resident level) according to PIDP are presented in Table 2 .
Outcome measures Table 3 presents the variation of PIDP and other potential drugrelated problems, with 67.7% (n = 426) of residents with PIDP: 63.4% (n = 399) had at least one drug with an unfavourable benefit-to-risk ratio (19.7% according to the Laroche list [39] , and 55.3% according to patients' clinical and biological data); 6.2% (n = 39) were exposed to at least one absolute contraindication; the presence of at least one significant drug-drug interaction concerned 4.6% (n = 29); 3.7% (n = 23) had at least one drug with questionable efficacy. PIDP decreased by 3.6% in the intervention group (68.8% to 65.2%) vs. 2.3% in the control group (72.2% to 69.9%). There was a decrease of drugs with unfavourable benefit-to-risk ratio and drugs with questionable efficacy, whereas there was an increase of absolute contraindications and a stability of significant drug-drug interactions. Long half-life BZD, proton pump inhibitors, neuroleptics and cerebral vasodilators were most frequently involved in PIDP. Table S2 presents drugs according to each component of PIDP.
Multivariable logistic regression analyses
For the primary outcome (PIDP), no significant inter-NH variance was found in Model 1 after factoring out the level-1 effects, leading to the use of a fixed effects logistic regression model ( Table 4) For secondary outcomes, significant inter-NH variance was found in Model 1 only for the prescription of drug with an unfavourable benefit-to-risk ratio (Table S3 ). In Model 2 (Table S3) , age (OR = 0.97; 95% CI 0.95-0.99) and dementia (OR = 0.39; 95% CI 0.24-0.62) were associated with a significantly decreased likelihood of drugs with an unfavourable benefit-to-risk ratio. Prescription of these drugs was associated with sex but not with comorbidities (Table S3) . The final multilevel model confirmed these results. The estimated inter-NH variance of 0.37 was significant in the empty model and did not decreased (variance = 0.37) after resident variables were added, meaning that inter-NH variability was not explained by the individual composition of the NH. It was reduced to 0.19 in the final adjusted model (full model; -48.6% compared to the empty model), by the introduction of the variable special care unit, this factor explaining 62.2% of the residual inter-NH variation. The likelihood of prescription of drugs with an unfavourable benefit-to-risk ratio was significantly lower when NH had a special care unit (OR = 0.43; 95% CI 0.26-0.70).
Discussion
This study showed that the general intervention of a geriatrician from the closest hospital, aiming to improve NH quality indicators through education and support of NH staff, significantly reduced PIDP in NH residents. Moreover, the likelihood of PIDP was significantly related to structural (presence of a special care unit) and organizational (access to psychiatric advice and/or to hospitalization in a psychiatric unit) NH characteristics. Living in a NH with a special care unit determines a part of the prescription of drugs with an unfavourable benefit-to-risk ratio.
Long half-life BZD were the more frequently involved drugs among those with an unfavourable benefit-to-risk ratio according to the Laroche list [39] and women were more likely to be exposed. Although prescription of these drugs decreased in the intervention group (-4.3%), whereas it increased in the control group (+0.5%); these differences were not statistically significant. However, BZD use (combining long-acting and other BZD) increased in both groups, as observed in a previous analysis of the IQUARE study focusing on the effects of the intervention on BZD use [46] . This finding was explained by the possible switch from meprobamate to BZD after the withdrawal from the market for safety reasons in January 2012. Actually, baseline use of meprobamate and hospitalization during the interval were the most important factors associated with new-use of BZD in both groups [46] . We cannot exclude that a more specifically designed intervention to reduce the use of drugs with an unfavourable benefit-to-risk ratio is needed. Actually, three strategies were possible in the intervention group and decided on an individual case basis for each NH: (i) involving only NH internal organization (implementation of regular use of scales for pain or behavioural disturbances); (ii) involving complex collaborative strategies (establishing a framework for facilitating access to health care, for example dental care in the NH); (iii) specific interventions of geriatricians, including for example telemedicine to present patients with behavioural disturbances or specific training on pain, diabetes or dementia care. By contrast, our findings underline the need to examine drug prescribing on a global perspective to avoid switching from specific drugs to other ones not necessarily safer. Table 3 Variation of prevalence of potentially inappropriate drug prescribing (PIDP) and other potential drug-related problems among residents between baseline and the follow-up time-point 
(continues)
PIDP was significantly related to structural and organizational NH characteristics, even if PIDP variability between NHs cannot be totally explained by these factors. Other NH variables not reported in our study would have contributed to explain it, for example, the fact that several physicians may have been involved in resident's drug prescription. We have chosen to look at drug prescribing as a whole, which implies that the criteria composing PIDP are of different nature and that their grouping may have minimized the random NH effect in multivariable models. A recent meta-analysis evaluating the impact of strategies to reduce polypharmacy on clinically outcomes (hospitalization and death) [47] found that various medical education interventions decreased the number of drugs prescribed and the number of patients with inappropriate prescriptions, and avoided the possible occurrence of adverse drug reactions and even generated significant savings in drug costs [48, 49] . Gaviria-Mendoza et al. [50] stated that various medical education interventions have improved rationalizing the use of drugs. It is of great importance to strengthen this kind of research in order to provide adequate, rational and cost-effective therapies.
Drug prescribing could be improved by the implementation of a real-time pharmaceutical analysis of drug prescriptions. Studies of pharmacist-led medication review in hospitals have added new insight into this subject [51] [52] [53] [54] [55] . A recent Cochrane review regarding outpatient care highlighted that the pharmacist's non-dispensing role was overall beneficial in improving patient outcomes [56] . However, this does not always seem feasible in the real world of the NH setting. All nursing home did not have a pharmacy for internal usage and there is little pharmaceutical presence. With a goal of sustainability, the implementation of repeated audits several times a year on various quality indicators or on specific aspects of residents' drug prescribing seems to be more appropriate for the NH setting. To this end, upstream training of community pharmacists intervening in NHs on the specificities of drug prescription in elderly subjects could be implemented. The general intervention implemented in the IQUARE study significantly reduced PIDP in NH residents. Admittedly, the significant reduction of PIDP is modest, but a global apprehension of the quality of care modestly improves the practices. In addition, being audited, with a perspective of all the quality indicators, raises awareness among all stakeholders.
The main strengths of this study are: (i) this is one of the first studies investigating PIDP in French NHs using a prospective design; (ii) the large sample size; (iii) the intervention was not directly focused on drug prescribing; (iv) our statistical approach, which took into account the clustercorrelated structure of the data; (v) the quality of drug data with a direct access to drug prescriptions and a high compliance because NH residents are closely monitored. The main limitations of this study are acknowledged: (i) IQUARE was a quasiexperimental study without random allocation for intervention. This choice was determined by the feasibility of a closed geriatric intervention among NH staff according to the NH environment (geriatric network, in French, filière gériatrique). Adjustment on confounding variables partly limited the importance of this bias. (ii) The high mortality rate (24.9% in this study) led to a high dropout rate, which may have somehow affected our results. (iii) The control group was also an active-control group since NHs participated in the audit and feedback phase of the study, we can suppose that the effectiveness of the intervention on reducing PIDP would have been higher if neither audit nor feedback had been done in the control group. (iv) Misclassification related to occasional drug use may represent a source of bias since we had information on drug prescriptions in the week of data collection and the duration of drug prescription was not available. However, previous studies have shown that inappropriate medication use remains in the long term for most older people [57] .
Conclusion
The general intervention implemented in the IQUARE study and designed to improve overall NH quality indicators succeeded in reducing PIDP. Our study provides important aspects that should be considered when constructing further new studies seeking to change prescribing patterns and to reduce the total number of drugs taken, but also to determine the final impact of these changes on clinical outcomes.
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